Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzybel International is a Belgian enzyme company focused on the extraction, refining, purification, and commercialization of natural proteases from plant and animal sources. Its portfolio includes bromelain, papain, ficin, pancreatin, chymotrypsin, and trypsin, which are sold into food and beverage, feed and pet food, nutraceutical, cosmetic, and pharmaceutical markets. In healthcare-related applications, the company supplies enzymes for pharma and nutraceutical uses including molecular biology, protein research, vaccine manufacturing support, and digestive and joint-health products. Enzybel appears to operate as a commercial specialty-ingredients and life-sciences manufacturer rather than a therapeutic drug developer. The company is part of the Floridienne life sciences ecosystem and has manufacturing operations in Europe and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzybel International.